发明公开
- 专利标题: Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
- 专利标题(中): 塞来昔酮治疗维生素E脱氢表雄酮(DHEA)
-
申请号: EP11174933.9申请日: 1999-06-10
-
公开(公告)号: EP2386305A2公开(公告)日: 2011-11-16
- 发明人: Labrie, Fernand
- 申请人: ENDORECHERCHE INC.
- 申请人地址: 2989 de la Promenade Sainte-Foy, Quebec G1W 2J5 CA
- 专利权人: ENDORECHERCHE INC.
- 当前专利权人: ENDORECHERCHE INC.
- 当前专利权人地址: 2989 de la Promenade Sainte-Foy, Quebec G1W 2J5 CA
- 代理机构: Bogensberger, Burkhard
- 优先权: US96284 19980611
- 主分类号: A61K31/565
- IPC分类号: A61K31/565 ; A61K45/06 ; A61P3/06 ; A61P9/00 ; A61P19/10
摘要:
Novel methods for the medical treatment and/or inhibition of the development of breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans involving administration of selective estrogen receptor modulator and an amount of a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3β,17β-diol, and compounds converted in vivo to one of the foregoing precursors.
Further administration of bisphosphonates in combination with selective estrogen receptor modulators and/or sex steroid precursors is disclosed. Pharmaceutical compositions for delivery of active ingredients and kits useful to the invention are disclosed.
Further administration of bisphosphonates in combination with selective estrogen receptor modulators and/or sex steroid precursors is disclosed. Pharmaceutical compositions for delivery of active ingredients and kits useful to the invention are disclosed.
公开/授权文献
信息查询